| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |